Interview with the Chairman and CEO: Theravance Biopharma Inc (NASDAQ:TBPH) twst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from twst.com Daily Mail and Mail on Sunday newspapers.
Q3 2023 YUPELRI® net sales, recognized by Viatris, increased 9% from Q3 2022, reaching an all-time high of $58.3 million1Progress made towards the achievement of non-GAAP profitability, with Q3.
Theravance Biopharma, Inc Reports Third Quarter 2023 Financial Results and Provides Business Update prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Theravance Biopharma, Inc Reports Third Quarter 2023 Financial Results and Provides Business Update lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Impax Asset Management Group plc boosted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,014 shares of the specialty pharmaceutical company’s stock after acquiring an additional 300 shares during […]